Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-L Lollini

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Cancer Research|February 10, 2000
Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice modelS Ménard, P Aiello, E Tagliabue, et al.
Anticancer Research|November 1, 1989
Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA)C De Giovanni, P Nanni, G Nicoletti, et al.
International Journal of Cancer|July 1, 1994
Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicinK Scotlandi, M Serra, M C Manara, et al.
Experimental and Clinical Immunogenetics|January 1, 1987
Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selectionC De Giovanni, P L Lollini, G Nicoletti, et al.
Experimental and Clinical Immunogenetics|January 1, 1985
In vivo reexpression of H-2 antigens in B16 melanoma cellsP L Lollini, M P Colombo, C De Giovanni, et al.
Journal of Immunogenetics|February 1, 1989
Tumorigenic and metastatic ability of SV40-transformed BALB/c cell lines and MHC antigen expressionC De Giovanni, G Nicoletti, B Del Re, et al.
Journal of Immunogenetics|October 1, 1983
Impaired H-2 expression in B16 melanoma variantsP Nanni, M P Colombo, C De Giovanni, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1993
Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamideA Andreani, M Rambaldi, A Locatelli, et al.
Transplantation Proceedings|June 21, 2005
Toward the definition of immunosuppressive regimens with antitumor activityF Casadio, S Croci, A D'Errico Grigioni, et al.
British Journal of Cancer|April 1, 1993
Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cellsC De Giovanni, P L Lollini, R Dolcetti, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Cancer Research|February 10, 2000
Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice modelS Ménard, P Aiello, E Tagliabue, et al.
Anticancer Research|November 1, 1989
Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA)C De Giovanni, P Nanni, G Nicoletti, et al.
International Journal of Cancer|July 1, 1994
Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicinK Scotlandi, M Serra, M C Manara, et al.
Experimental and Clinical Immunogenetics|January 1, 1987
Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selectionC De Giovanni, P L Lollini, G Nicoletti, et al.
Experimental and Clinical Immunogenetics|January 1, 1985
In vivo reexpression of H-2 antigens in B16 melanoma cellsP L Lollini, M P Colombo, C De Giovanni, et al.
Journal of Immunogenetics|February 1, 1989
Tumorigenic and metastatic ability of SV40-transformed BALB/c cell lines and MHC antigen expressionC De Giovanni, G Nicoletti, B Del Re, et al.
Journal of Immunogenetics|October 1, 1983
Impaired H-2 expression in B16 melanoma variantsP Nanni, M P Colombo, C De Giovanni, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1993
Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamideA Andreani, M Rambaldi, A Locatelli, et al.
Transplantation Proceedings|June 21, 2005
Toward the definition of immunosuppressive regimens with antitumor activityF Casadio, S Croci, A D'Errico Grigioni, et al.
British Journal of Cancer|April 1, 1993
Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cellsC De Giovanni, P L Lollini, R Dolcetti, et al.
Pageof 11